These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 26631103

  • 1. A pilot randomized, placebo-controlled clinical trial to investigate the efficacy and safety of an extract of Artemisia annua administered over 12 weeks, for managing pain, stiffness, and functional limitation associated with osteoarthritis of the hip and knee.
    Stebbings S, Beattie E, McNamara D, Hunt S.
    Clin Rheumatol; 2016 Jul; 35(7):1829-36. PubMed ID: 26631103
    [Abstract] [Full Text] [Related]

  • 2. An open-label six-month extension study to investigate the safety and efficacy of an extract of Artemisia annua for managing pain, stiffness and functional limitation associated with osteoarthritis of the hip and knee.
    Hunt S, Stebbings S, McNamara D.
    N Z Med J; 2016 Oct 28; 129(1444):97-102. PubMed ID: 27806033
    [Abstract] [Full Text] [Related]

  • 3. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A, Ma C, Ahdieh H, Galer BS.
    Clin Ther; 2006 Mar 28; 28(3):352-64. PubMed ID: 16750450
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of low-dose SoluMatrix meloxicam in the treatment of osteoarthritis pain: a 12-week, phase 3 study.
    Altman R, Hochberg M, Gibofsky A, Jaros M, Young C.
    Curr Med Res Opin; 2015 Dec 28; 31(12):2331-43. PubMed ID: 26503347
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of low-dose submicron diclofenac for the treatment of osteoarthritis pain: a 12 week, phase 3 study.
    Gibofsky A, Hochberg MC, Jaros MJ, Young CL.
    Curr Med Res Opin; 2014 Sep 28; 30(9):1883-93. PubMed ID: 25050589
    [Abstract] [Full Text] [Related]

  • 6. A randomized double-blind placebo-controlled trial to investigate the effectiveness and safety of a novel green-lipped mussel extract -BioLex® -for managing pain in moderate to severe osteoarthritis of the hip and knee.
    Stebbings S, Gray A, Schneiders AG, Sansom A.
    BMC Complement Altern Med; 2017 Aug 22; 17(1):416. PubMed ID: 28830491
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of E-OA-07 in moderate to severe symptoms of osteoarthritis: a double-blind randomized placebo-controlled study.
    Kulkarni MP, Shakeel A, Shinde BS, Rosenbloom RA.
    Am J Ther; 2011 Aug 22; 18(2):170-7. PubMed ID: 21317618
    [Abstract] [Full Text] [Related]

  • 8. Randomized clinical trial evaluating transdermal Ibuprofen for moderate to severe knee osteoarthritis.
    Varadi G, Zhu Z, Blattler T, Hosle M, Loher A, Pokorny R, Frey D, Carter SG.
    Pain Physician; 2013 Aug 22; 16(6):E749-62. PubMed ID: 24284856
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.
    Balanescu AR, Feist E, Wolfram G, Davignon I, Smith MD, Brown MT, West CR.
    Ann Rheum Dis; 2014 Sep 22; 73(9):1665-72. PubMed ID: 23852695
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of individualized Chinese herbal medication in osteoarthrosis of hip and knee: a double-blind, randomized-controlled clinical study.
    Lechner M, Steirer I, Brinkhaus B, Chen Y, Krist-Dungl C, Koschier A, Gantschacher M, Neumann K, Zauner-Dungl A.
    J Altern Complement Med; 2011 Jun 22; 17(6):539-47. PubMed ID: 21649520
    [Abstract] [Full Text] [Related]

  • 11. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
    Temple AR, Benson GD, Zinsenheim JR, Schweinle JE.
    Clin Ther; 2006 Feb 22; 28(2):222-35. PubMed ID: 16678643
    [Abstract] [Full Text] [Related]

  • 12. Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trial.
    Strand V, Bergman M, Singh JA, Gibofsky A, Kivitz A, Young C.
    Clin Rheumatol; 2017 Jun 22; 36(6):1357-1367. PubMed ID: 28194525
    [Abstract] [Full Text] [Related]

  • 13. Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial.
    Schnitzer TJ, Easton R, Pang S, Levinson DJ, Pixton G, Viktrup L, Davignon I, Brown MT, West CR, Verburg KM.
    JAMA; 2019 Jul 02; 322(1):37-48. PubMed ID: 31265100
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of twice daily sustained-release paracetamol formulation for osteoarthritis pain of the knee or hip: a randomized, double-blind, placebo-controlled, twelve-week study.
    Reed K, Collaku A, Moreira S.
    Curr Med Res Opin; 2018 Apr 02; 34(4):689-699. PubMed ID: 29239664
    [Abstract] [Full Text] [Related]

  • 15. Greater reduction of knee than hip pain in osteoarthritis treated with naproxen, as evaluated by WOMAC and SF-36.
    Svensson O, Malmenäs M, Fajutrao L, Roos EM, Lohmander LS.
    Ann Rheum Dis; 2006 Jun 02; 65(6):781-4. PubMed ID: 16269428
    [Abstract] [Full Text] [Related]

  • 16. Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trial.
    DeLemos BP, Xiang J, Benson C, Gana TJ, Pascual ML, Rosanna R, Fleming B.
    Am J Ther; 2011 May 02; 18(3):216-26. PubMed ID: 20215961
    [Abstract] [Full Text] [Related]

  • 17. Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial.
    Petrella RJ, DiSilvestro MD, Hildebrand C.
    Arch Intern Med; 2002 Feb 11; 162(3):292-8. PubMed ID: 11822921
    [Abstract] [Full Text] [Related]

  • 18. Prospective, randomized, double-blinded, double-dummy and multicenter phase IV clinical study comparing the efficacy and safety of PG201 (Layla) and SKI306X in patients with osteoarthritis.
    Ha CW, Park YB, Min BW, Han SB, Lee JH, Won YY, Park YS.
    J Ethnopharmacol; 2016 Apr 02; 181():1-7. PubMed ID: 26821189
    [Abstract] [Full Text] [Related]

  • 19. Huo-Luo-Xiao-Ling (HLXL)-Dan, a Traditional Chinese Medicine, for patients with osteoarthritis of the knee: a multi-site, randomized, double-blind, placebo-controlled phase II clinical trial.
    Lao L, Hochberg M, Lee DYW, Gilpin AMK, Fong HHS, Langenberg P, Chen K, Li EK, Tam LS, Berman B.
    Osteoarthritis Cartilage; 2015 Dec 02; 23(12):2102-2108. PubMed ID: 26099553
    [Abstract] [Full Text] [Related]

  • 20. Duloxetine added to oral nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: results of a randomized, double-blind, placebo-controlled trial.
    Frakes EP, Risser RC, Ball TD, Hochberg MC, Wohlreich MM.
    Curr Med Res Opin; 2011 Dec 02; 27(12):2361-72. PubMed ID: 22017192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.